Maximal Inhibition of Intestinal First-Pass Metabolism as a Pragmatic Indicator of Intestinal Contribution to the Drug-Drug Interactions for CYP3A4 Cleared Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|8|7|685-693

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.8, Iss.7, 2007-10, pp. : 685-693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential role of intestinal first-pass metabolism in the prediction of drug–drug interactions

By Galetin Aleksandra   Gertz Michael   Houston J Brian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 909-922

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Intestinal First-Pass Drug Metabolism

By  

Current Drug Metabolism, Vol. 8, Iss. 7, 2007-10 ,pp. : 676-684

Bentham Science Publishers

Access to resources Recommend Favorite

Predicting Drug-Drug Interactions Involving the Inhibition of Intestinal CYP3A4 and P-Glycoprotein

By  

Current Drug Metabolism, Vol. 11, Iss. 9, 2010-11 ,pp. : 762-777

Bentham Science Publishers

Access to resources Recommend Favorite

Visualization of First-Pass Drug Metabolism of Terfenadine by MALDIImaging Mass Spectrometry

By  

Drug Metabolism Letters, Vol. 2, Iss. 1, 2008-01 ,pp. : 1-4

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of In Vivo Drug-Drug Interactions from In Vitro Data: Factors Affecting Prototypic Drug-Drug Interactions Involving CYP2C9, CYP2D6 and CYP3A4

By Brown Hayley S.   Galetin Aleksandra   Hallifax David   Houston J. Brian  

Clinical Pharmacokinetics, Vol. 45, Iss. 10, 2006-01 ,pp. : 1035-1050

Adis International

Access to resources Recommend Favorite